Dexmedetomidine-Ketamine Infusion in Breast Surgeries

Summary

* This is a prospective randomized double blind controlled study. * Female patients undergoing radical mastectomy will be included in this study where they will be randomly allocated into; - Control group in which patients will receive continuous infusion of normal saline. Dexmedetomidine-Ketamine group in which patients will receive continuous infusion of ketamine and dexmedetomidine. The intraoperative and postoperative opioid consumption will be measured. Also, the postoperative pain score and the incidence of chronic pain will be assessed.

Timeline

Start

2019-09-01

Primary completion

2024-03-20

Completion

2024-03-20

Drugs

Indications

No indication recorded.